Abnormal 0 8 0 8 B-chronic_disease
bleeding 9 17 9 17 I-chronic_disease
times 18 23 18 23 I-chronic_disease
or 24 26 24 26 O
active 27 33 27 33 O
anti 34 38 34 38 B-treatment
- 38 39 38 39 I-treatment
coagulation 39 50 39 50 I-treatment
therapy 51 58 51 58 I-treatment

Age 0 3 59 62 B-age
greater 4 11 63 70 O
than 12 16 71 75 O
18 17 19 76 78 B-lower_bound
years 20 25 79 84 I-lower_bound
of 26 28 85 87 O
age 29 32 88 91 B-age

Any 0 3 92 95 O
patient 4 11 96 103 O
or 12 14 104 106 O
tumor 15 20 107 112 B-cancer
/ 20 21 112 113 O
anatomical 21 31 113 123 O
factors 32 39 124 131 O
that 40 44 132 136 O
may 45 48 137 140 O
prevent 49 56 141 148 O
brachytherapy 57 70 149 162 B-treatment
apparatus 71 80 163 172 O
from 81 85 173 177 O
being 86 91 178 183 O
properly 92 100 184 192 O
and 101 104 193 196 O
safely 105 111 197 203 O
inserted 112 120 204 212 O
and 121 124 213 216 O
positioned 125 135 217 227 O
and 136 139 228 231 O
from 140 144 232 236 O
radiation 145 154 237 246 B-treatment
therapy 155 162 247 254 I-treatment
being 163 168 255 260 O
administered 169 181 261 273 O
per 182 185 274 277 O
ABS 186 189 278 281 O
guidelines 190 200 282 292 O

Cervical 0 8 293 301 B-cancer
cancer 9 15 302 308 I-cancer

Clinically 0 10 309 319 O
significant 11 22 320 331 O
unrelated 23 32 332 341 O
systemic 33 41 342 350 O
illness 42 49 351 358 O
( 50 51 359 360 O
serious 51 58 360 367 B-chronic_disease
infections 59 69 368 378 I-chronic_disease
or 70 72 379 381 O
significant 73 84 382 393 O
cardiac 85 92 394 401 B-chronic_disease
, 92 93 401 402 O
pulmonary 94 103 403 412 B-chronic_disease
, 103 104 412 413 O
hepatic 105 112 414 421 B-chronic_disease
or 113 115 422 424 O
other 116 121 425 430 O
organ 122 127 431 436 B-chronic_disease
dysfunction 128 139 437 448 I-chronic_disease
) 139 140 448 449 O
, 140 141 449 450 O
which 142 147 451 456 O
in 148 150 457 459 O
the 151 154 460 463 O
judgment 155 163 464 472 O
of 164 166 473 475 O
the 167 170 476 479 O
Principal 171 180 480 489 O
or 181 183 490 492 O
Associate 184 193 493 502 O
Investigator 194 206 503 515 O
would 207 212 516 521 O
compromise 213 223 522 532 O
the 224 227 533 536 O
patient 228 235 537 544 O
s 236 237 545 546 O
ability 238 245 547 554 O
to 246 248 555 557 O
tolerate 249 257 558 566 O
this 258 262 567 571 O
therapy 263 270 572 579 B-treatment
or 271 273 580 582 O
are 274 277 583 586 O
likely 278 284 587 593 O
to 285 287 594 596 O
interfere 288 297 597 606 O
with 298 302 607 611 O
the 303 306 612 615 O
study 307 312 616 621 O
procedures 313 323 622 632 O
or 324 326 633 635 O
results 327 334 636 643 O

ECOG 0 4 644 648 B-clinical_variable
performance 5 16 649 660 I-clinical_variable
status 17 23 661 667 I-clinical_variable
of 24 26 668 670 O
0 27 28 671 672 B-lower_bound
, 28 29 672 673 O
1 30 31 674 675 O
, 31 32 675 676 O
or 33 35 677 679 O
2 36 37 680 681 B-upper_bound

Endometrial 0 11 682 693 B-cancer
cancer 12 18 694 700 I-cancer

Gynecologic 0 11 701 712 B-cancer
Cancers 12 19 713 720 I-cancer

Infiltrating 0 12 721 733 B-cancer
ductal 13 19 734 740 I-cancer
carcinoma 20 29 741 750 I-cancer
or 30 32 751 753 O
DCIS 33 37 754 758 B-cancer
, 37 38 758 759 O
stage 39 44 760 765 O
T0 45 47 766 768 B-clinical_variable
, 47 48 768 769 O
T1 49 51 770 772 B-clinical_variable
, 51 52 772 773 O
and 53 56 774 777 O
T2 57 59 778 780 B-clinical_variable
less 60 64 781 785 O
than 65 69 786 790 O
or 70 72 791 793 O
equal 73 78 794 799 O
to 79 81 800 802 O
3.0 82 85 803 806 B-upper_bound
cm 86 88 807 809 I-upper_bound
, 88 89 809 810 O
N0 90 92 811 813 O
and 93 96 814 817 O
M0 97 99 818 820 O

Lung 0 4 821 825 B-cancer
cancer 5 11 826 832 I-cancer

PT 0 2 833 835 B-clinical_variable
/ 2 3 835 836 I-clinical_variable
PTT 3 6 836 839 I-clinical_variable
greater 7 14 840 847 O
than 15 19 848 852 O
1.5 20 23 853 856 B-lower_bound
the 24 27 857 860 O
upper 28 33 861 866 B-clinical_variable
normal 34 40 867 873 I-clinical_variable
limit 41 46 874 879 I-clinical_variable
( 47 48 880 881 I-clinical_variable
UNL 48 51 881 884 I-clinical_variable
) 51 52 884 885 I-clinical_variable

Pathologically 0 14 886 900 O
confirmed 15 24 901 910 O
malignancy 25 35 911 921 B-cancer
for 36 39 922 925 O
which 40 45 926 931 O
high 46 50 932 936 B-treatment
- 50 51 936 937 I-treatment
dose 51 55 937 941 I-treatment
rate 56 60 942 946 I-treatment
brachytherapy 61 74 947 960 I-treatment
is 75 77 961 963 O
appropriate 78 89 964 975 O
as 90 92 976 978 O
a 93 94 979 980 O
component 95 104 981 990 O
of 105 107 991 993 O
their 108 113 994 999 O
therapeutic 114 125 1000 1011 O
regimen 126 133 1012 1019 O

Patients 0 8 1020 1028 O
at 9 11 1029 1031 O
a 12 13 1032 1033 O
higher 14 20 1034 1040 O
risk 21 25 1041 1045 O
of 26 28 1046 1048 O
recurrence 29 39 1049 1059 O
( 40 41 1060 1061 O
because 41 48 1061 1068 O
of 49 51 1069 1071 O
either 52 58 1072 1078 O
grade 59 64 1079 1084 O
, 64 65 1084 1085 O
myometrial 66 76 1086 1096 B-cancer
invasion 77 85 1097 1105 I-cancer
, 85 86 1105 1106 O
lymphatic 87 96 1107 1116 B-cancer
vascular 97 105 1117 1125 I-cancer
space 106 111 1126 1131 I-cancer
invasion 112 120 1132 1140 I-cancer
, 120 121 1140 1141 O
tumor 122 127 1142 1147 B-cancer
size 128 132 1148 1152 O
, 132 133 1152 1153 O
lymph 134 139 1154 1159 O
node 140 144 1160 1164 O
status 145 151 1165 1171 O
, 151 152 1171 1172 O
tumor 153 158 1173 1178 O
extension 159 168 1179 1188 O
, 168 169 1188 1189 O
presence 170 178 1190 1198 O
or 179 181 1199 1201 O
absence 182 189 1202 1209 O
of 190 192 1210 1212 O
surgical 193 201 1213 1221 O
staging 202 209 1222 1229 O
) 209 210 1229 1230 O

Patients 0 8 1231 1239 O
benefiting 9 19 1240 1250 O
from 20 24 1251 1255 O
HDR 25 28 1256 1259 B-treatment
as 29 31 1260 1262 O
either 32 38 1263 1269 O
as 39 41 1270 1272 O
a 42 43 1273 1274 O
boost 44 49 1275 1280 B-treatment
or 50 52 1281 1283 I-treatment
accelerated 53 64 1284 1295 I-treatment
partial 65 72 1296 1303 I-treatment
breast 73 79 1304 1310 I-treatment
irradiation 80 91 1311 1322 I-treatment
regimen 92 99 1323 1330 I-treatment

Patients 0 8 1331 1339 O
currently 9 18 1340 1349 O
receiving 19 28 1350 1359 O
concurrent 29 39 1360 1370 O
investigational 40 55 1371 1386 B-treatment
chemotherapeutic 56 72 1387 1403 I-treatment
agents 73 79 1404 1410 I-treatment

Patients 0 8 1411 1419 O
inappropriate 9 22 1420 1433 O
for 23 26 1434 1437 O
standard 27 35 1438 1446 O
breast 36 42 1447 1453 B-treatment
conservation 43 55 1454 1466 I-treatment
therapy 56 63 1467 1474 I-treatment
( 64 65 1475 1476 O
Multicentric 65 77 1476 1488 B-cancer
disease 78 85 1489 1496 I-cancer
, 85 86 1496 1497 O
inability 87 96 1498 1507 O
to 97 99 1508 1510 O
achieve 100 107 1511 1518 O
clear 108 113 1519 1524 O
margins 114 121 1525 1532 O
) 121 122 1532 1533 O

Patients 0 8 1534 1542 O
of 9 11 1543 1545 O
childbearing 12 24 1546 1558 O
or 25 27 1559 1561 O
child- 28 34 1562 1568 O
fathering 35 44 1569 1578 O
potential 45 54 1579 1588 O
must 55 59 1589 1593 O
be 60 62 1594 1596 O
willing 63 70 1597 1604 B-contraception_consent
to 71 73 1605 1607 I-contraception_consent
use 74 77 1608 1611 I-contraception_consent
a 78 79 1612 1613 I-contraception_consent
medically 80 89 1614 1623 I-contraception_consent
acceptable 90 100 1624 1634 I-contraception_consent
form 101 105 1635 1639 I-contraception_consent
of 106 108 1640 1642 I-contraception_consent
birth 109 114 1643 1648 I-contraception_consent
control 115 122 1649 1656 I-contraception_consent
, 122 123 1656 1657 O
which 124 129 1658 1663 O
includes 130 138 1664 1672 O
abstinence 139 149 1673 1683 O
, 149 150 1683 1684 O
while 151 156 1685 1690 O
they 157 161 1691 1695 O
are 162 165 1696 1699 O
being 166 171 1700 1705 O
treated 172 179 1706 1713 O
on 180 182 1714 1716 O
this 183 187 1717 1721 O
study 188 193 1722 1727 O

Patients 0 8 1728 1736 O
receiving 9 18 1737 1746 O
concomitant 19 30 1747 1758 B-treatment
chemotherapy 31 43 1759 1771 I-treatment
administration 44 58 1772 1786 O
in 59 61 1787 1789 O
the 62 65 1790 1793 O
5 66 67 1794 1795 O
days 68 72 1796 1800 O
preceding 73 82 1801 1810 O
brachytherapy 83 96 1811 1824 B-treatment

Patients 0 8 1825 1833 O
who 9 12 1834 1837 O
are 13 16 1838 1841 O
unable 17 23 1842 1848 O
to 24 26 1849 1851 O
undergo 27 34 1852 1859 O
surgery 35 42 1860 1867 B-treatment
and 43 46 1868 1871 O
must 47 51 1872 1876 O
have 52 56 1877 1881 O
treatment 57 66 1882 1891 B-treatment
for 67 70 1892 1895 O
an 71 73 1896 1898 O
inoperable 74 84 1899 1909 O
primary 85 92 1910 1917 B-cancer
cervical 93 101 1918 1926 I-cancer
cancer 102 108 1927 1933 I-cancer

Patients 0 8 1934 1942 O
who 9 12 1943 1946 O
are 13 16 1947 1950 O
unable 17 23 1951 1957 O
to 24 26 1958 1960 O
undergo 27 34 1961 1968 O
surgery 35 42 1969 1976 B-treatment
and 43 46 1977 1980 O
must 47 51 1981 1985 O
have 52 56 1986 1990 O
treatment 57 66 1991 2000 B-treatment
for 67 70 2001 2004 O
an 71 73 2005 2007 O
inoperable 74 84 2008 2018 O
primary 85 92 2019 2026 O
endometrial 93 104 2027 2038 B-cancer
cancer 105 111 2039 2045 I-cancer

Patients 0 8 2046 2054 O
who 9 12 2055 2058 O
can 13 16 2059 2062 O
not 17 20 2063 2066 O
undergo 21 28 2067 2074 O
resection 29 38 2075 2084 O
because 39 46 2085 2092 O
of 47 49 2093 2095 O
poor 50 54 2096 2100 O
lung 55 59 2101 2105 O
function 60 68 2106 2114 O
or 69 71 2115 2117 O
distant 72 79 2118 2125 O
lung 80 84 2126 2130 B-cancer
metastasis 85 95 2131 2141 I-cancer

Patients 0 8 2142 2150 O
with 9 13 2151 2155 O
localized 14 23 2156 2165 B-cancer
prostate 24 32 2166 2174 I-cancer
cancer 33 39 2175 2181 I-cancer
( 40 41 2182 2183 I-cancer
T1b 41 44 2183 2186 I-cancer
- 44 45 2186 2187 I-cancer
T3b 45 48 2187 2190 I-cancer
) 48 49 2190 2191 I-cancer
in 50 52 2192 2194 O
whom 53 57 2195 2199 O
brachytherapy 58 71 2200 2213 B-treatment
will 72 76 2214 2218 O
be 77 79 2219 2221 O
integrated 80 90 2222 2232 O
as 91 93 2233 2235 O
a 94 95 2236 2237 O
boost 96 101 2238 2243 O
to 102 104 2244 2246 O
external 105 113 2247 2255 B-treatment
beam 114 118 2256 2260 I-treatment
radiation 119 128 2261 2270 I-treatment
or 129 131 2271 2273 O
used 132 136 2274 2278 O
as 137 139 2279 2281 O
monotherapy 140 151 2282 2293 B-treatment
for 152 155 2294 2297 O
definitive 156 166 2298 2308 O
management 167 177 2309 2319 O

Patients 0 8 2320 2328 O
with 9 13 2329 2333 O
locally 14 21 2334 2341 B-cancer
advanced 22 30 2342 2350 I-cancer
cervical 31 39 2351 2359 I-cancer
cancer 40 46 2360 2366 I-cancer
in 47 49 2367 2369 O
whom 50 54 2370 2374 O
brachytherapy 55 68 2375 2388 B-treatment
will 69 73 2389 2393 O
be 74 76 2394 2396 O
integrated 77 87 2397 2407 O
as 88 90 2408 2410 O
a 91 92 2411 2412 O
boost 93 98 2413 2418 O
to 99 101 2419 2421 O
external 102 110 2422 2430 B-treatment
beam 111 115 2431 2435 I-treatment
radiation 116 125 2436 2445 I-treatment
either 126 132 2446 2452 O
in 133 135 2453 2455 O
a 136 137 2456 2457 O
palliative 138 148 2458 2468 O
or 149 151 2469 2471 I-treatment
curative 152 160 2472 2480 I-treatment
setting 161 168 2481 2488 I-treatment
( 169 170 2489 2490 O
definitive 170 180 2490 2500 O
or 181 183 2501 2503 O
post 184 188 2504 2508 O
- 188 189 2508 2509 O
operative 189 198 2509 2518 O
setting 199 206 2519 2526 O
) 206 207 2526 2527 O

Pregnant 0 8 2528 2536 B-pregnancy
or 9 11 2537 2539 O
breast 12 18 2540 2546 O
- 18 19 2546 2547 O
feeding 19 26 2547 2554 O
females 27 34 2555 2562 B-gender
are 35 38 2563 2566 O
excluded 39 47 2567 2575 O
because 48 55 2576 2583 O
of 56 58 2584 2586 O
the 59 62 2587 2590 O
potential 63 72 2591 2600 O
mutagenic 73 82 2601 2610 O
effects 83 90 2611 2618 O
on 91 93 2619 2621 O
a 94 95 2622 2623 O
developing 96 106 2624 2634 O
fetus 107 112 2635 2640 O
or 113 115 2641 2643 O
newborn 116 123 2644 2651 O

Prostate 0 8 2652 2660 B-cancer
Cancer 9 15 2661 2667 I-cancer

Prostate 0 8 2668 2676 B-cancer
cancer 9 15 2677 2683 I-cancer

autoimmune 0 10 2684 2694 B-chronic_disease
disorders 11 20 2695 2704 I-chronic_disease
, 20 21 2704 2705 O
including 22 31 2706 2715 O
SLE 32 35 2716 2719 B-chronic_disease
, 35 36 2719 2720 O
Scleroderma 37 48 2721 2732 B-chronic_disease
, 48 49 2732 2733 O
etc 50 53 2734 2737 O

distant 0 7 2738 2745 B-cancer
metastases 8 18 2746 2756 I-cancer

gynecological 0 13 2757 2770 B-cancer
cancer 14 20 2771 2777 I-cancer
patients 21 29 2778 2786 O
who 30 33 2787 2790 O
may 34 37 2791 2794 O
have 38 42 2795 2799 O
received 43 51 2800 2808 O
concurrent 52 62 2809 2819 O
chemotherapy 63 75 2820 2832 B-treatment
as 76 78 2833 2835 O
a 79 80 2836 2837 O
component 81 90 2838 2847 O
of 91 93 2848 2850 O
their 94 99 2851 2856 O
treatment 100 109 2857 2866 O
regimen 110 117 2867 2874 O

lymph 0 5 2875 2880 B-cancer
node 6 10 2881 2885 I-cancer
metastases 11 21 2886 2896 I-cancer

male 0 4 2897 2901 B-gender
patients 5 13 2902 2910 I-gender
with 14 18 2911 2915 O
breast 19 25 2916 2922 B-cancer
cancer 26 32 2923 2929 I-cancer

platelets 0 9 2930 2939 B-clinical_variable
less 10 14 2940 2944 O
than 15 19 2945 2949 O
100,000 20 27 2950 2957 B-upper_bound
per 28 31 2958 2961 I-upper_bound
mm(3 32 36 2962 2966 I-upper_bound
) 36 37 2966 2967 I-upper_bound

